Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Leber's Hereditary Optic Neuropathy Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Leber's Hereditary Optic Neuropathy Drugmarket, defines the market attractiveness level of Leber's Hereditary Optic Neuropathy Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Leber's Hereditary Optic Neuropathy Drug industry, describes the types of Leber's Hereditary Optic Neuropathy Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Leber's Hereditary Optic Neuropathy Drug market and the development prospects and opportunities of Leber's Hereditary Optic Neuropathy Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Leber's Hereditary Optic Neuropathy Drug market in Chapter 13.
By Player:
Biovista Inc
Stealth BioTherapeutics Inc
Spark Therapeutics, Inc
Alkeus Pharmaceuticals, Inc
GenSight Biologics SA
Khondrion BV
Ixchel Pharma, LLC
By Type:
Elamipretide
GS-011
IXC-201
KH-176
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Leber's Hereditary Optic Neuropathy Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Leber's Hereditary Optic Neuropathy Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Leber's Hereditary Optic Neuropathy Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Leber's Hereditary Optic Neuropathy Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Leber's Hereditary Optic Neuropathy Drug Market Analysis and Outlook to 2022
-
7.1 Global Leber's Hereditary Optic Neuropathy Drug Consumption (2017-2022)
-
7.2 United States Leber's Hereditary Optic Neuropathy Drug Consumption (2017-2022)
-
7.3 Europe Leber's Hereditary Optic Neuropathy Drug Consumption (2017-2022)
-
7.4 China Leber's Hereditary Optic Neuropathy Drug Consumption (2017-2022)
-
7.5 Japan Leber's Hereditary Optic Neuropathy Drug Consumption (2017-2022)
-
7.6 India Leber's Hereditary Optic Neuropathy Drug Consumption (2017-2022)
-
7.7 South Korea Leber's Hereditary Optic Neuropathy Drug Consumption (2017-2022)
8 Region and Country-wise Leber's Hereditary Optic Neuropathy Drug Market Analysis and Outlook to 2028
-
8.1 Global Leber's Hereditary Optic Neuropathy Drug Consumption Forecast (2022-2028)
-
8.2 United States Leber's Hereditary Optic Neuropathy Drug Consumption Forecast (2022-2028)
-
8.3 Europe Leber's Hereditary Optic Neuropathy Drug Consumption Forecast (2022-2028)
-
8.4 China Leber's Hereditary Optic Neuropathy Drug Consumption Forecast (2022-2028)
-
8.5 Japan Leber's Hereditary Optic Neuropathy Drug Consumption Forecast (2022-2028)
-
8.6 India Leber's Hereditary Optic Neuropathy Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Leber's Hereditary Optic Neuropathy Drug Consumption Forecast (2022-2028)
9 Global Leber's Hereditary Optic Neuropathy Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Leber's Hereditary Optic Neuropathy Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Elamipretide Consumption and Growth Rate (2017-2022)
-
9.1.2 Global GS-011 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global IXC-201 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global KH-176 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Leber's Hereditary Optic Neuropathy Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Leber's Hereditary Optic Neuropathy Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Leber's Hereditary Optic Neuropathy Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Elamipretide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global GS-011 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global IXC-201 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global KH-176 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Leber's Hereditary Optic Neuropathy Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Leber's Hereditary Optic Neuropathy Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Leber's Hereditary Optic Neuropathy Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Leber's Hereditary Optic Neuropathy Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Leber's Hereditary Optic Neuropathy Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Leber's Hereditary Optic Neuropathy Drug Market Competitive Analysis
-
14.1 Biovista Inc
-
14.1.1 Biovista Inc Company Details
-
14.1.2 Biovista Inc Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biovista Inc Leber's Hereditary Optic Neuropathy Drug Product and Service
-
14.2 Stealth BioTherapeutics Inc
-
14.2.1 Stealth BioTherapeutics Inc Company Details
-
14.2.2 Stealth BioTherapeutics Inc Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Stealth BioTherapeutics Inc Leber's Hereditary Optic Neuropathy Drug Product and Service
-
14.3 Spark Therapeutics, Inc
-
14.3.1 Spark Therapeutics, Inc Company Details
-
14.3.2 Spark Therapeutics, Inc Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Spark Therapeutics, Inc Leber's Hereditary Optic Neuropathy Drug Product and Service
-
14.4 Alkeus Pharmaceuticals, Inc
-
14.4.1 Alkeus Pharmaceuticals, Inc Company Details
-
14.4.2 Alkeus Pharmaceuticals, Inc Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Alkeus Pharmaceuticals, Inc Leber's Hereditary Optic Neuropathy Drug Product and Service
-
14.5 GenSight Biologics SA
-
14.5.1 GenSight Biologics SA Company Details
-
14.5.2 GenSight Biologics SA Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GenSight Biologics SA Leber's Hereditary Optic Neuropathy Drug Product and Service
-
14.6 Khondrion BV
-
14.6.1 Khondrion BV Company Details
-
14.6.2 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product and Service
-
14.7 Ixchel Pharma, LLC
-
14.7.1 Ixchel Pharma, LLC Company Details
-
14.7.2 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Leber's Hereditary Optic Neuropathy Drug
-
Figure Leber's Hereditary Optic Neuropathy Drug Picture
-
Table Global Leber's Hereditary Optic Neuropathy Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Leber's Hereditary Optic Neuropathy Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Leber's Hereditary Optic Neuropathy Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Leber's Hereditary Optic Neuropathy Drug Consumption by Country (2017-2022)
-
Figure United States Leber's Hereditary Optic Neuropathy Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Leber's Hereditary Optic Neuropathy Drug Consumption and Growth Rate (2017-2022)
-
Figure China Leber's Hereditary Optic Neuropathy Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Leber's Hereditary Optic Neuropathy Drug Consumption and Growth Rate (2017-2022)
-
Figure India Leber's Hereditary Optic Neuropathy Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Leber's Hereditary Optic Neuropathy Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Leber's Hereditary Optic Neuropathy Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Leber's Hereditary Optic Neuropathy Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Leber's Hereditary Optic Neuropathy Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Leber's Hereditary Optic Neuropathy Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Leber's Hereditary Optic Neuropathy Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Leber's Hereditary Optic Neuropathy Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Leber's Hereditary Optic Neuropathy Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Elamipretide Consumption and Growth Rate (2017-2022)
-
Figure Global GS-011 Consumption and Growth Rate (2017-2022)
-
Figure Global IXC-201 Consumption and Growth Rate (2017-2022)
-
Figure Global KH-176 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Elamipretide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GS-011 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IXC-201 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global KH-176 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Leber's Hereditary Optic Neuropathy Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Leber's Hereditary Optic Neuropathy Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Biovista Inc (Foundation Year, Company Profile and etc.)
-
Table Biovista Inc Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biovista Inc Leber's Hereditary Optic Neuropathy Drug Product and Service
-
Table Stealth BioTherapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Stealth BioTherapeutics Inc Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stealth BioTherapeutics Inc Leber's Hereditary Optic Neuropathy Drug Product and Service
-
Table Spark Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Spark Therapeutics, Inc Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spark Therapeutics, Inc Leber's Hereditary Optic Neuropathy Drug Product and Service
-
Table Alkeus Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Alkeus Pharmaceuticals, Inc Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkeus Pharmaceuticals, Inc Leber's Hereditary Optic Neuropathy Drug Product and Service
-
Table GenSight Biologics SA (Foundation Year, Company Profile and etc.)
-
Table GenSight Biologics SA Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GenSight Biologics SA Leber's Hereditary Optic Neuropathy Drug Product and Service
-
Table Khondrion BV (Foundation Year, Company Profile and etc.)
-
Table Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product and Service
-
Table Ixchel Pharma, LLC (Foundation Year, Company Profile and etc.)
-
Table Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product and Service
-
